Women's Health Ultrasound

In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

Check out top radiology content from the past week.

The portable ATUSA™ System reportedly provides 3D ultrasound visualization of the entire breast volume in two minutes.

Review top radiology content from the week.

A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.

What is your diagnosis?

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

Review top radiology content from the week.

Preliminary ultrasound findings from a study of over 3,000 women in early pregnancy found no association between fetal anomalies and initial COVID-19 vaccination.

Review top radiology content from the week.

Review top radiology content from the week.

Review top radiology content from the week.

The expanded FDA clearance for Collaboration Live (Philips) gives clinicians the option to consult on or diagnose ultrasound images from their mobile devices.

In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.

In addition to newly added advances with hemodynamic assessment and obstetric measurements, Lumify also offers a B-line quantification tool and AI-enhanced algorithms that may bolster ultrasound lung imaging in severe COVID-19 cases.

Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.

What is your diagnosis?

Much more than a minimum bar to meet, standardization is our foundation for elevating the level of care and outcomes for all patients.

Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.

Investigators at Massachusetts General Hospital proposed an algorithm for appropriate axillary nodal imaging to better align with changes in treatment algorithms for axillary nodal disease in patients with breast cancer.

Artificial intelligence can help seek out and identify high-risk patients who might benefit from more extensive screening.

Advancements in image quality and advanced technologies in ultrasound devices such as shearwave imaging can help.

40-week-old male with a prenatally diagnosed abnormality on screening ultrasound. What is the diagnosis?

Known as the "Swiss Army knife" of healthcare, point-of-care ultrasound—or POCUS—has come a long way.

Feminizing hormone therapy may increase the risk of breast cancer in transgender women, a growing body of research suggests, underscoring a need for health care providers to understand the risks, breast imaging features, and health care needs of this demographic.

Including a DNA-methylation analysis could improve early diagnosis for BI-RADS 4 patients.

Non-invasive test misses more than four times the number of endometrial cancer cases in Black women than with white counterparts.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

No difference was seen between women who were screened yearly and those who did not undergo annual exams.